Sentence examples for survival have focused from inspiring English sources

Prospective trials aimed to improve the RR, time to progression (TTP) and survival have focused on dose intensification of cisplatin in combination with VP16.

Previous studies regarding IC therapy survival have focused on total intensive care unit (ICU) patients, including post-operative patients with short ICU stays [ 4, 5], or have focused on specific populations, such as the elderly, cancer patients or mechanically ventilated patients [ 6– 9].

The majority of studies aimed at evaluating the predictive power of Akt phosphorylation for patient survival have focussed on Ser473 rather than Thr308 phosphorylation, probably in large part because phosphoSer473 antibodies are relatively effective, particularly in immunohistochemical (IHC) analyses.

To improve survival, strategies have focused on early presentation (reducing delay to improve stage at diagnosis), improving quality of care and ensuring equity throughout the patient pathway.

Efforts to improve cell survival and integration have focused in part on the development of biocompatible scaffolds that support neural cell growth and function.

In the search for new targets for prognosis and survival, several studies have focused on angiogenesis.

To improve survival, numerous studies have focused on exploring the feasibility and efficacy of consolidation chemotherapy (CCT) following concurrent CRT with discordant results.

Although it is recognized that hyperlactatemia is a common occurrence in critically ill patients and is associated with increased mortality, and that the resolution of hyperlactatemia is associated with increased survival, previous studies have focused on relatively small cohorts of selected critically ill populations [ 1- 3, 5- 7, 9- 12].

To improve survival, strategies in England have focused on early presentation (reducing delay to improve stage at diagnosis), improving quality of care and ensuring equity throughout the patient pathway.

A number of recent studies have focused on patient survival and kidney survival after acute renal failure.

Past studies have focused on survival in the presence of antibiotics by individual cells, as genetic mutants or persisters.